NVIDIA CorporationNvidia targets healthcare as a major AI growth market, with potential sales from hospitals, research labs, and drug developers.

Nvidia is targeting healthcare as its next major growth market for artificial intelligence. Kimberly Powell, Nvidia's vice president of healthcare, told the Financial Times that the industry has a huge opportunity to use AI as hospitals deal with worker shortages and rising demand. The company sees AI assisting with research, clinical tools, automation, and medical robots, and it recently launched the Vera Rubin NVL4 platform for scientific supercomputers while reportedly working with Abridge on an AI tool for doctor's notes. Drug research could also benefit from faster computing to test molecules and study diseases more quickly. For Nvidia, healthcare provides another market beyond chips for AI data centers, and investors will watch whether early interest translates into real sales across hospitals, research labs, and drug developers.
NVIDIA CorporationNvidia targets healthcare as a major AI growth market, with potential sales from hospitals, research labs, and drug developers.
Nvidia is reportedly working with Abridge on an AI tool for doctor's notes, indicating a partnership that could benefit Abridge.